ASSESSING THE PUBLIC HEALTH IMPACT OF THE ADJUVANTED RESPIRATORY SYNCYTIAL VIRUS PREFUSION F PROTEIN VACCINE AMONG OLDER ADULTS IN THE UNITED STATES (US)

被引：0
|
作者：
Molnar, D. [1 ]
La, E. M. [2 ]
Verelst, F. [1 ]
Curran, D. [1 ]
Poston, S. [2 ]
Van Bellinghen, L. A. [3 ]
Graham, J.
机构：
[1] GSK, Wavre, WBR, Belgium
[2] GSK, Philadelphia, PA USA
[3] CHESS Hlth, Bonheiden, Belgium
来源：
VALUE IN HEALTH | 2023年 / 26卷 / 06期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EPH45
引用
收藏
页码：S172 / S172
页数：1
相关论文
共 50 条
  • [31] Efficacy and Safety of Respiratory Syncytial Virus (RSV) Prefusion F Protein Vaccine (RSVPreF3 OA) in Older Adults Over 2 RSV Seasons
    Ison, Michael G.
    Papi, Alberto
    Athan, Eugene
    Feldman, Robert G.
    Langley, Joanne M.
    Lee, Dong-Gun
    Leroux-Roels, Isabel
    Martinon-Torres, Federico
    Schwarz, Tino F.
    van Zyl-Smit, Richard N.
    Verheust, Celine
    Dezutter, Nancy
    Gruselle, Olivier
    Fissette, Laurence
    David, Marie-Pierre
    Kostanyan, Lusine
    Hulstrom, Veronica
    Olivier, Aurelie
    van der Wielen, Marie
    Descamps, Dominique
    CLINICAL INFECTIOUS DISEASES, 2024, 78 (06) : 1732 - 1744
  • [32] Efficacy, Immunogenicity, and Safety of the Bivalent Respiratory Syncytial Virus (RSV) Prefusion F Vaccine in Older Adults Over 2 RSV Seasons
    Walsh, Edward E.
    Eiras, Daniel
    Woodside, John
    Jiang, Qin
    Patton, Michael
    Marc, Gonzalo Perez
    Llapur, Conrado
    Ramet, Mika
    Fukushima, Yasushi
    Hussen, Nazreen
    Cardona, Jose
    Mikati, Tarek
    Zareba, Agnieszka
    Ilangovan, Kumar
    Lino, Maria Maddalena
    Kalinina, Elena, V
    Swanson, Kena A.
    Gurtman, Alejandra
    Munjal, Iona
    RENOIR Clin Trial Grp
    CLINICAL INFECTIOUS DISEASES, 2025,
  • [33] Potential public health impact of vaccination against respiratory syncytial virus using the adjuvanted RSVPreF3 in older adults in Hong Kong
    Ho, Yufan
    Seneviratna, Aruni
    Chau, Clementine
    Man, Katie
    Shantakumar, Sumitra
    RESPIROLOGY, 2024, 29 : 39 - 39
  • [34] Safety and immunogenicity of the respiratory syncytial virus (RSV) prefusion F protein vaccine (RSVPreF3 OA) in Asian older adults (≥60 years of age)
    Hwang, Shinn-Jang
    Lee, Dong-Gun
    Liu, Chiu-Shong
    Park, Dae Won
    Takazawa, Kenji
    Yono, Makoto
    Deraedt, Quentin
    De Schrevel, Nathalie
    Kuriyakose, Sherine
    Hulstrom, Veronica
    Kotb, Shady
    Van der Wielen, Marie
    RESPIROLOGY, 2023, 28 : 83 - 84
  • [35] Immunogenicity and safety of a respiratory syncytial virus fusion protein (RSV F) nanoparticle vaccine in older adults
    Louis Fries
    Vivek Shinde
    Jeffrey J. Stoddard
    D. Nigel Thomas
    Eloi Kpamegan
    Hanxin Lu
    Gale Smith
    Somia P. Hickman
    Pedro Piedra
    Gregory M. Glenn
    Immunity & Ageing, 14
  • [36] Immunogenicity and safety of a respiratory syncytial virus fusion protein (RSV F) nanoparticle vaccine in older adults
    Fries, Louis
    Shinde, Vivek
    Stoddard, Jeffrey J.
    Thomas, D. Nigel
    Kpamegan, Eloi
    Lu, Hanxin
    Smith, Gale
    Hickman, Somia P.
    Piedra, Pedro
    Glenn, Gregory M.
    IMMUNITY & AGEING, 2017, 14
  • [37] Immunogenicity and Safety of the Bivalent Respiratory Syncytial Virus Prefusion F Subunit Vaccine in Immunocompromised or Renally Impaired Adults
    Almeida, Natalia Castillo
    Parameswaran, Lalitha
    Dehaan, Elliot N.
    Wyper, Hayley
    Rahman, Farah
    Jiang, Qin
    Li, Wen
    Patton, Michael
    Lino, Maria Maddalena
    Majid-Mahomed, Zaynah
    Malkin, Elissa
    Davis, Matthew
    Towner, William J.
    Saharia, Kapil
    Ilangovan, Kumar
    Kalinina, Elena
    Cooper, David
    Swanson, Kena A.
    Anderson, Annaliesa S.
    Gurtman, Alejandra
    Munjal, Iona
    VACCINES, 2025, 13 (03)
  • [38] Cost-Effectiveness of Bivalent Respiratory Syncytial Virus Prefusion F (RSVpreF) Vaccine During Pregnancy for Prevention of Respiratory Syncytial Virus Among Infants in Argentina
    Rey-Ares, Lucila
    Averin, Ahuva
    Zuccarino, Nadia
    Vega, Celina Guadalupe
    Kutrieb, Emily
    Quinn, Erin
    Atwood, Mark
    Weycker, Derek
    Law, Amy W.
    INFECTIOUS DISEASES AND THERAPY, 2024, 13 (11) : 2363 - 2376
  • [39] Efficacy, Immunogenicity, and Safety of an Investigational Maternal Respiratory Syncytial Virus Prefusion F Protein-Based Vaccine
    Banooni, Peyman
    Gonik, Bernard
    Epalza, Cristina
    Reyes, Osvaldo
    Madhi, Shabir A.
    Gomez-Go, Grace Devota
    Zaman, Khalequ
    Llapur, Conrado Juan
    Lopez-Medina, Eduardo
    Stanley, Thorsten
    Kantele, Anu
    Huang, Li-Min
    Mussi-Pinhata, Marisa Marcia
    Dewulf, Jonas
    Langley, Joanne M.
    Seidl, Claudia
    Ota, Martin
    Kirabo, Martha
    Anspach, Bruno
    Dieussaert, Ilse
    Henry, Ouzama
    Kim, Joon Hyung
    Picciolato, Marta
    InvestiGational RSV mAternal vacCinE GRACE Study Grp
    CLINICAL INFECTIOUS DISEASES, 2025,
  • [40] Enhanced Neutralizing Antibody Response Induced by Respiratory Syncytial Virus Prefusion F Protein Expressed by a Vaccine Candidate
    Liang, Bo
    Surman, Sonja
    Amaro-Carambot, Emerito
    Kabatova, Barbora
    Mackow, Natalie
    Lingemann, Matthias
    Yang, Lijuan
    McLellan, Jason S.
    Graham, Barney S.
    Kwong, Peter D.
    Schaap-Nutt, Anne
    Collins, Peter L.
    Munir, Shirin
    JOURNAL OF VIROLOGY, 2015, 89 (18) : 9499 - 9510
12345